Henriette Nielsen to lead 'transformation' at Hikma

Hikma Pharmaceuticals announced the appointment of Henriette Nielsen to the newly-created role of chief transformation officer on Monday.

The FTSE 250 company said that in the role, Nielsen would be responsible for leading a number of initiatives across Hikma's global operations to improve operational efficiency and ensure that it achieved its strategic objectives.

She would join Hikma's executive committee, and would report directly to chief executive officer Siggi Olafsson.

Nielsen’s appointment was effective from Monday.

“Henriette brings extensive experience in pharmaceutical operations and transformation projects and has a strong track record of formulating and executing global strategic initiatives and developing multi-functional work plans,” said Siggi Olafsson.

“She brings an entrepreneurial attitude that I am confident will fit well within the Hikma culture.”

Henriette Nielsen was joining Hikma from Teva Pharmaceuticals USA, where she was most recently senior vice-president, chief transformation officer, global marketing and portfolio.

Hikma’s board said her previous experience included being the founder of System Matters, a healthcare and impact investing consultancy, and general counsel and executive vice-president at Actavis Group.

Nielsen also held senior roles at Alpharma, Netdoktor and Kromann Reumert.